All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Chugai Pharmaceutical Co., Ltd. revenue reports

Chugai Pharmaceutical Co., Ltd. financial reports, Chugai Pharmaceutical Co., Ltd. annual revenue in 2024. When does Chugai Pharmaceutical Co., Ltd. report revenue?
Add to widgets
Added to widgets

Chugai Pharmaceutical Co., Ltd. total revenue, net income and dynamics of changes in Euro today

Net revenue of Chugai Pharmaceutical Co., Ltd. on 30/06/2021 amounted to 221 411 000 000 €. The dynamics of Chugai Pharmaceutical Co., Ltd. net revenue increased by 52 594 000 000 € from the last reporting period. Net income, revenue and dynamics - the main financial indicators of Chugai Pharmaceutical Co., Ltd.. Chugai Pharmaceutical Co., Ltd. financial report on a graph in real time displays the dynamics, i.e. change in fixed assets of the company. Chugai Pharmaceutical Co., Ltd. net income is shown in blue on the graph. A graph of the value of all Chugai Pharmaceutical Co., Ltd. assets is presented in green bars.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
30/06/2021 206 404 869 475 € +33.38 % ↑ 65 932 545 350 € +106.66 % ↑
31/03/2021 157 375 427 825 € +9.42 % ↑ 44 197 719 475 € +35.34 % ↑
31/12/2020 196 164 377 850 € +18.66 % ↑ 48 762 825 300 € +30.23 % ↑
30/09/2020 194 275 690 000 € +10.52 % ↑ 56 057 485 925 € +24.91 % ↑
31/12/2019 165 314 255 925 € - 37 442 817 125 € -
30/09/2019 175 785 939 350 € - 44 878 243 725 € -
30/06/2019 154 746 553 325 € - 31 904 468 400 € -
31/03/2019 143 831 130 800 € - 32 656 773 975 € -
Show:
to

Chugai Pharmaceutical Co., Ltd. financial report charts

The latest dates of Chugai Pharmaceutical Co., Ltd. financial statements available online: 31/03/2019, 31/03/2021, 30/06/2021. The dates of the financial statements are determined by the accounting rules. The latest date of the financial report of Chugai Pharmaceutical Co., Ltd. is 30/06/2021. Gross profit Chugai Pharmaceutical Co., Ltd. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Chugai Pharmaceutical Co., Ltd. is 153 352 000 000 €

Chugai Pharmaceutical Co., Ltd. quarterly report dates

Cost of revenue Chugai Pharmaceutical Co., Ltd. is the total cost of producing and distributing of products and services of a company. Cost of revenue Chugai Pharmaceutical Co., Ltd. is 68 059 000 000 € Total revenue Chugai Pharmaceutical Co., Ltd. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Chugai Pharmaceutical Co., Ltd. is 221 411 000 000 € Operating income Chugai Pharmaceutical Co., Ltd. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Chugai Pharmaceutical Co., Ltd. is 96 712 000 000 €

Net income Chugai Pharmaceutical Co., Ltd. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Chugai Pharmaceutical Co., Ltd. is 70 726 000 000 € Current assets Chugai Pharmaceutical Co., Ltd. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Chugai Pharmaceutical Co., Ltd. is 857 123 000 000 € Total assets Chugai Pharmaceutical Co., Ltd. refers to the total amount of assets owned by a person or entity. Total assets Chugai Pharmaceutical Co., Ltd. is 1 275 767 000 000 €

30/06/2021 31/03/2021 31/12/2020 30/09/2020 31/12/2019 30/09/2019 30/06/2019 31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
142 958 568 200 € 105 787 960 775 € 128 797 138 225 € 129 618 428 450 € 105 586 600 175 € 106 782 644 850 € 95 017 033 125 € 84 254 495 500 €
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
63 446 301 275 € 51 587 467 050 € 67 367 239 625 € 64 657 261 550 € 59 727 655 750 € 69 003 294 500 € 59 729 520 200 € 59 576 635 300 €
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
206 404 869 475 € 157 375 427 825 € 196 164 377 850 € 194 275 690 000 € 165 314 255 925 € 175 785 939 350 € 154 746 553 325 € 143 831 130 800 €
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - - - - -
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
90 157 344 200 € 59 630 704 350 € 68 902 614 200 € 80 814 585 250 € 46 349 294 775 € 61 364 642 850 € 45 640 803 775 € 42 969 979 150 €
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
65 932 545 350 € 44 197 719 475 € 48 762 825 300 € 56 057 485 925 € 37 442 817 125 € 44 878 243 725 € 31 904 468 400 € 32 656 773 975 €
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
31 287 335 450 € 27 712 252 575 € 30 606 811 200 € 28 100 058 175 € 28 927 873 975 € 23 388 593 025 € 24 874 559 675 € 23 435 204 275 €
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
116 247 525 275 € 97 744 723 475 € 127 261 763 650 € 113 461 104 750 € 118 964 961 150 € 114 421 296 500 € 109 105 749 550 € 100 861 151 650 €
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
799 031 488 675 € 690 751 690 475 € 778 320 245 850 € 692 019 516 475 € 652 259 188 000 € 622 762 656 775 € 591 259 977 350 € 558 299 298 025 €
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
1 189 301 891 575 € 1 067 049 905 075 € 1 151 762 123 050 € 1 059 108 280 300 € 987 147 035 875 € 955 843 852 600 € 919 751 829 500 € 869 059 298 450 €
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
174 448 196 475 € 151 066 129 025 € 197 942 130 925 € 170 327 761 975 € 190 118 898 725 € 165 024 333 950 € 139 055 342 125 € 117 290 685 050 €
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
- - - - 167 118 111 300 € 166 188 682 975 € 148 771 923 300 € 127 270 153 675 €
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
- - - - 191 040 869 250 € 197 818 145 000 € 181 275 812 375 € 160 135 746 050 €
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
- - - - 19.35 % 20.70 % 19.71 % 18.43 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
980 754 769 050 € 916 011 742 800 € 913 583 296 675 € 862 559 825 750 € 796 106 166 625 € 758 025 707 600 € 738 476 017 125 € 708 923 552 400 €
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - 73 280 342 800 € 58 484 999 825 € 30 069 849 600 € 30 800 714 000 €

Last revenue report of Chugai Pharmaceutical Co., Ltd. was 30/06/2021. According to last financial report total revenue in Chugai Pharmaceutical Co., Ltd. was 206 404 869 475 Euro and changed by +33.38% since last year. Net income in Chugai Pharmaceutical Co., Ltd. was 65 932 545 350 € in last quartal, net income changes to +106.66%.

Current cash Chugai Pharmaceutical Co., Ltd. - the sum of all of the cash a company has on the date of report. Current cash Chugai Pharmaceutical Co., Ltd. is 187 131 000 000 €

Chugai Pharmaceutical Co., Ltd. stocks data

Chugai Pharmaceutical Co., Ltd. financials